×

Photo Release -- Medical Marijuana, Inc.'s HempMeds Gains Global Media Exposure at New York Cannabis Business Conference & Expo

SAN DIEGO, Oct. 16, 2014 (GLOBE NEWSWIRE) -- New York is the most recent state to pass medical marijuana laws and an estimated 900 people explored ways to get into the state's emerging cannabis industry including HempMeds™ – a Medical Marijuana, Inc. (OTC Pink:MJNA) portfolio company and the world's most trusted supplier of natural cannabidiol (CBD) hemp oil products. The Company proudly showcased current products and unveiled innovations in its CBD hemp oil product line at the International Cannabis Association's East Coast Regulatory Summit and Educational Conference. New York's first and largest cannabis business conference was held Oct. 12 and 13 at the Marquis Marriott Hotel in Times Square. There, HempMeds™ participated as an exhibitor and as the conference's industry party sponsor distributing hemp CBD oil samples to attendees.



Kate Rogers from CNBC Interviews Dr. "Doc Rob" Streisfeld on Cannabis for People ...and Pets!


A photo accompanying this release is available at http://www.globenewswire.com/newsroom/prs/?pkgid=28417

"Participating in the International Cannabis Association's New York business conference and expo aided the public with understanding that cannabidiol or 'CBD' is available today," states Andrew Hard, Director of Public Relations for HempMeds™. "To say that we are thrilled at the receptivity of the mainstream news media's willingness to report on natural CBD hemp oil is an understatement. At the ICA's business expo, we were inundated by many members of regional, national and global news media with interest in natural CBD oil products on the market and in development."

Reporting on natural CBD hemp oil were media outlets including Reuters, Reuters UK, Avax News pictures, Fortune Magazine, and CNBC. Additional reports about the International Cannabis Association's New York business conference and expo are being published in the coming days as well.

Hard continues, "From supplying CBD hemp oil as a raw ingredient to manufacturers or finished products for people and pets, HempMeds™ is very excited at the multiple new avenues for business development that resulted from the International Cannabis Association's historic conference. We thank the news media, people of New York, Senator Savino, and the east coast business community. All made this a truly historic event for the advancement of the cannabis industry and natural CBD oil products in New York and on the east coast."

For more information on HempMeds and their all-natural CBD hemp oil products, visit: www.hempmeds.com. The Company invites the public to get involved in the conversation of the expanding cannabis industry with HempMeds™ through the Company's social media websites on Facebook and Twitter.

About HempMeds

HempMeds™ offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMeds™ is a corporate portfolio company of Medical Marijuana, Inc. (OTC Pink:MJNA) and the Company's exclusive master distributor and contracted marketing company. In addition to handling sales and distribution, HempMeds™ is the communication hub for the Medical Marijuana Inc. portfolio of companies.

About Medical Marijuana Inc.

Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company's website at: www.MedicalMarijuanaInc.com

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

LEGAL DISCLOSURE

Medical Marijuana Inc. and HempMeds do not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

The photo is also available at Newscom, www.newscom.com, and via AP PhotoExpress.

CONTACT: Investor Relations contact: Perry Coleman Medical Marijuana, Inc. P. 443-453-5088 perry@medicalmarijuanainc.com Public Relations contact: Andrew Hard Director of PR, HempMeds P. 858-380-5478 andrew.hard@hempmeds.com Corporate contact: Medical Marijuana, Inc. Toll Free: 888-OTC-MJNA (888-682-6562) www.medicalmarijuanainc.com www.facebook.com/mjnainc

Source:Medical Marijuana Inc